Trademark: 87614556
Status Date
Monday, May 10, 2021
Filing Date
Tuesday, September 19, 2017
Published for Opposition
Tuesday, February 6, 2018
Abandoned Date
Monday, May 10, 2021
5 Pharmaceuticals, namely, anti-cancer drugs; Pharmaceutical preparations for the treatment of various cancers utilizing liposomal drug delivery technology
May 10, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
May 10, 2021
Abandonment - No Use Statement Filed
Oct 3, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 2, 2020
Extension 5 Granted
Sep 26, 2020
Extension 5 Filed
Oct 2, 2020
Case Assigned To Intent To Use Paralegal
Sep 26, 2020
Teas Extension Received
Apr 1, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 30, 2020
Extension 4 Granted
Mar 30, 2020
Extension 4 Filed
Mar 30, 2020
Teas Extension Received
Oct 5, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 3, 2019
Extension 3 Granted
Oct 3, 2019
Extension 3 Filed
Oct 3, 2019
Teas Extension Received
Nov 14, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 12, 2018
Extension 2 Granted
Nov 12, 2018
Extension 2 Filed
Nov 12, 2018
Teas Extension Received
Apr 10, 2018
Notice Of Approval Of Extension Request E-Mailed
Apr 6, 2018
Extension 1 Granted
Apr 6, 2018
Extension 1 Filed
Apr 6, 2018
Teas Extension Received
Apr 3, 2018
Noa E-Mailed - Sou Required From Applicant
Feb 6, 2018
Official Gazette Publication Confirmation E-Mailed
Feb 6, 2018
Published For Opposition
Jan 17, 2018
Notification Of Notice Of Publication E-Mailed
Dec 22, 2017
Approved For Pub - Principal Register
Dec 22, 2017
Assigned To Examiner
Sep 25, 2017
New Application Office Supplied Data Entered In Tram
Sep 22, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
